Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.22.2
Related Party Transactions (Details Narrative)
6 Months Ended
Jun. 30, 2022
Tactic Pharma LLC  
Beneficial Ownership 34.00%